Post-approval studies (Phase 4)Study completedNCT04792190
What this trial is testing
Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation
Who this might be right for
Atrial Fibrillation
University of Rochester 25